Navigation Links
PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs
Date:2/1/2012

ghout Asia," said Seong-Wook Park, M.D. Ph.D, President and CEO, ASAN Medical Center. "We look forward to collaborating with PAREXEL through our Department of Clinical Pharmacology and Therapeutics to promote, facilitate, and enhance the development and use of novel pharmacotherapeutics."

The AMC Clinical Trial Center, which opened in 2002, is a leading center in Korea that supports clinical trials conducted by ASAN Medical Center. It was designated as the Regional Clinical Trial Center by the Korean Ministry for Health, Welfare, and Family Affairs in 2006. The government's investment made it possible for the center to rapidly build infrastructure.  The center provides high quality clinical trial services, and assures quality through its Quality Assurance Unit, sponsor audits, and inspections by regulatory authorities. The center incorporates the well-established Department of Clinical Pharmacology and Therapeutics.

PAREXEL is one of Asia's leading providers of biopharmaceutical services. The Company has had a presence in the Asia/Pacific region for over 16 years. PAREXEL has more than 2,800 employees and 21 offices throughout important industry centers in the region, including locations in Australia, China, Hong Kong, India, Indonesia, Japan, Malaysia, the Philippines, Singapore, South Korea, Taiwan, and Thailand. PAREXEL experts support biopharmaceutical companies in accessing diverse patient populations, navigating regulatory issues, identifying investigators, and ensuring data quality throughout the Asia/Pacific region.

About ASAN Medical CenterThe ASAN Medical Center is a patient-centered medical complex and large, premier clinical-research centered hospital. The Ministry of Health and Welfare designated ASAN Medical Center as an innovative cancer research-centered hospital. The Clinical Research Center for Ischemic Diseases and the Clinical Research Center for Chronic Respiratory Obstruction Diseases were chosen to host research p
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
2. PAREXEL International to Present at J.P. Morgan Healthcare Conference
3. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
4. PAREXEL International to Present at Robert Baird Healthcare Conference and William Blair Emerging Growth Stock Conference
5. PAREXEL Ranks as a "Best 5 Outsourcing Company for the Pharmaceutical Industry" by IAOP®
6. PAREXEL Named Company of the Year for the Pharmaceutical Industry in International Business Awards(SM)
7. PAREXEL International to Present at Wells Fargo Healthcare Conference
8. Pfizer Inc. and PAREXEL International Corp. Sign Strategic Partnership Agreement to Advance Clinical Development
9. PAREXEL Reports Second Quarter Fiscal Year 2011 Financial Results
10. PAREXEL Announces Date of Second Quarter Fiscal Year 2011 Earnings Release and Conference Call
11. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Ill. , May 26, 2015  AbbVie ... announced today that it has completed the acquisition ... presence in oncology. Pharmacyclics is a leader in ... first-in-class BTK-inhibitor used to treat hematological cancers, a ... shared expertise, combined with AbbVie,s broad late-stage oncology ...
(Date:5/26/2015)... 2015 PRC Clinical, the Clinical ... for Regenerative Medicine (ARM). The ARM counts more ... and commercialization of transformational treatments and cures for ... California-based CRO focused in Clinical Trial Management, has ... regenerative research working with sponsors in the United ...
(Date:5/25/2015)... , May 26, 2015  PureTech, a science-driven ... health challenges in disruptive ways, announced today that Dame ... and former CEO of Pearson, has been appointed to ... Independent Director and that current Board member Joi ... Board Chairman. Dr. Ben Shapiro , PureTech,s outgoing ...
(Date:5/25/2015)... The 2015 Market Research Report ... professional and in-depth study on the current state ... with a focus on the Chinese situation. Major ... are Linde Industrial Gas, Basf, Air Products, Air ... Group, Longsheng Group, Juhua Group, Wandali Gas, Unid(Jiangsu) ...
Breaking Biology Technology:AbbVie Completes Acquisition of Pharmacyclics 2AbbVie Completes Acquisition of Pharmacyclics 3AbbVie Completes Acquisition of Pharmacyclics 4AbbVie Completes Acquisition of Pharmacyclics 5AbbVie Completes Acquisition of Pharmacyclics 6PRC Clinical Joins 200+ Member Organizations in The Alliance for Regenerative Medicine (ARM) 2PRC Clinical Joins 200+ Member Organizations in The Alliance for Regenerative Medicine (ARM) 3PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 2PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 3Global Hydrogen Chloride Industry 2015 Trends and Analysis Available in a New Report at DeepResearchReports.com 2Global Hydrogen Chloride Industry 2015 Trends and Analysis Available in a New Report at DeepResearchReports.com 3
... Million; GAAP EPS $0.34; ... Adjusted EPS $0.35, Fiscal Year 2007: Total Net Revenue Reaches $2.50 ... $1.27; 2007 Adjusted EPS ... leading specialty pharmaceutical,company, today reported fourth quarter and full year 2007 financial results,for its ...
... Cylex, Inc., today announced the,publication of an independent, ... of cellular immune response measured prior to kidney,transplantation ... was found to identify patients that may be ... kidney function in the first three,months following transplantation., ...
... supplier of,innovative services to healthcare providers, announced today ... its Cardiovascular Program.,VascularAware is designed to help people ... (PAD), which affects nearly 10 million adult Americans,according ... the VascularAware disease module extends the Company,s,mission of ...
Cached Biology Technology:Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 2Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 3Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 4Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 5Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 6Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 7Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 8Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 9Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 10Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 11Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 12Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 13Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 14Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 15Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 16Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 17Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook 18New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 2New Independent Research Study Indicates That Cylex's ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection 3HealthAware Introduces Its VascularAware Cardiovascular Disease Module 2
(Date:5/22/2015)... , May 22, 2015 According ... by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, ... (Government and Utilities, Consumer and Home) - Global Forecast ... grow from $2.77 Billion in 2015 to $6.19 Billion ... Browse 79 market data Tables and   43 ...
(Date:5/20/2015)... 20, 2015 ... announced the addition of the  "5-year ... Recognition Market"  report to their offering.  ... service analyses trends in the iris ... commercial sectors, globally. Despite hardware pricing ...
(Date:5/19/2015)... -- Technology is rapidly advancing, outpacing enterprises, ability to secure ... and their management are soon to be rendered obsolete ... as those developed by the FIDO Alliance™. With the ... BYOD, COPE, IoT, and mobile payments, the interconnected online ... In response to the call for seamless, secure, ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
... The international research team led by Chinese Academy of ... and analysis of a diploid cotton-- Gossypium raimondii ... the study and genetic improvement of cotton quality and ... characteristics and evolutionary mechanism underlying cotton and its close ...
... Immediate Release August 28, 2012 (Toronto) Six ... (CAMH) have received prestigious NARSAD Young Investigator Grants from ... awards will fund research on biological factors underlying schizophrenia, ... stimulation and brain imaging techniques, which promise to lead ...
... An international team of scientists has discovered the oldest ... crustaceanspreserved in amber. The specimens, one fly and two ... Italy, are about 100 million years older than any ... are published today in the Proceedings of the ...
Cached Biology News:Chinese scientists successfully crack the genome of diploid cotton 26 NARSAD Young Investigator Grants awarded to CAMH 26 NARSAD Young Investigator Grants awarded to CAMH 3Scientists find oldest occurrence of arthropods preserved in amber 2Scientists find oldest occurrence of arthropods preserved in amber 3
... of UVP's Doc-It systems. When further analysis ... software onto your existing computer. Doc-It ... enhancement tools. Doc-It 1D Analysis Software provides ... quick and accurate electrophoresis analysis., Enhance-It ...
CQCS kit for first KR 4i , (first unit)....
... new generation dispenser combining the most versatile features ... of the existing Multidrop dispensers. , ,It ... from 500 nl up to 2500 l with ... is optimized for multiple plate formats (96, 384, ...
Multidrop Micro high speed 1 l bulk reagent dispenser rapidly, precisely and accurately dispenses microvolumes of 1-50 l into 384- and 96-well microplates....
Biology Products: